These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 20350194)

  • 1. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of single-dose artesunate plus sulfalene/pyrimethamine combined with praziquantel for the treatment of children with Schistosoma mansoni or Schistosoma haematobium in western Kenya: a randomised, open-label controlled trial.
    Obonyo CO; Rawago FO; Makworo NK; Muok EMO
    Parasit Vectors; 2024 Jun; 17(1):279. PubMed ID: 38943214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study.
    Borrmann S; Szlezák N; Faucher JF; Matsiegui PB; Neubauer R; Binder RK; Lell B; Kremsner PG
    J Infect Dis; 2001 Nov; 184(10):1363-6. PubMed ID: 11679932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial.
    Soukhathammavong P; Odermatt P; Sayasone S; Vonghachack Y; Vounatsou P; Hatz C; Akkhavong K; Keiser J
    Lancet Infect Dis; 2011 Feb; 11(2):110-8. PubMed ID: 21111681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
    Keiser J; Silué KD; Adiossan LK; N'Guessan NA; Monsan N; Utzinger J; N'Goran EK
    PLoS Negl Trop Dis; 2014 Jul; 8(7):e2975. PubMed ID: 25033291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.
    Garba A; Lamine MS; Barkiré N; Djibo A; Sofo B; Gouvras AN; Labbo R; Sebangou H; Webster JP; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):334-44. PubMed ID: 22940014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
    Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
    Barda B; Coulibaly JT; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    PLoS Negl Trop Dis; 2016 Sep; 10(9):e0005008. PubMed ID: 27636542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a combination of praziquantel and artesunate in the treatment of urinary schistosomiasis in Nigeria.
    Inyang-Etoh PC; Ejezie GC; Useh MF; Inyang-Etoh EC
    Trans R Soc Trop Med Hyg; 2009 Jan; 103(1):38-44. PubMed ID: 18838149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections.
    N'Goran EK; Utzinger J; Gnaka HN; Yapi A; N'Guessan NA; Kigbafori SD; Lengeler C; Chollet J; Shuhua X; Tanner M
    Am J Trop Med Hyg; 2003 Jan; 68(1):24-32. PubMed ID: 12556143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
    Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T
    Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks.
    Boulanger D; Dieng Y; Cisse B; Remoue F; Capuano F; Dieme JL; Ndiaye T; Sokhna C; Trape JF; Greenwood B; Simondon F
    Trans R Soc Trop Med Hyg; 2007 Feb; 101(2):113-6. PubMed ID: 16765398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.
    Basra A; Mombo-Ngoma G; Melser MC; Diop DA; Würbel H; Mackanga JR; Fürstenau M; Zoleko RM; Adegnika AA; Gonzalez R; Menendez C; Kremsner PG; Ramharter M
    Clin Infect Dis; 2013 Mar; 56(6):e68-75. PubMed ID: 23175561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of praziquantel against Schistosoma haematobium infection in children.
    Tchuenté LA; Shaw DJ; Polla L; Cioli D; Vercruysse J
    Am J Trop Med Hyg; 2004 Dec; 71(6):778-82. PubMed ID: 15642971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for treating urinary schistosomiasis.
    Kramer CV; Zhang F; Sinclair D; Olliaro PL
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD000053. PubMed ID: 25099517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
    Keiser J; Manneck T; Vargas M
    J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.